https://doi.org/10.1038/s41388-018-0534-3
Y
Yanli Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
269
Papers
4.1K
Citations
34
h-index
94
i10-index
Yanli Li is an academic researcher from Shanghai University. The author has contributed to research in topics: Cancer-related molecular mechanisms research & MicroRNA in disease regulation & RNA modifications and cancer. The author has an h-index of 34, co-authored 229 publications.
ORCID: 0000-0002-2936-0339Papers by this author
worksOncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP
2018 · Oncogene · 80 citations
MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN
2019 · Biomedicine & Pharmacotherapy · 75 citations
https://doi.org/10.1016/j.biopha.2018.12.115
Investigation of SP94 Peptide as a Specific Probe for Hepatocellular Carcinoma Imaging and Therapy
2016 · Scientific Reports · 36 citations
https://doi.org/10.1038/srep33511
The microRNA-195 - BDNF pathway and cognitive deficits in schizophrenia patients with minimal antipsychotic medication exposure
2021 · Translational Psychiatry · 36 citations
https://doi.org/10.1038/s41398-021-01240-x
Long non-coding RNA and mRNA profile analysis of metformin to reverse the pulmonary hypertension vascular remodeling induced by monocrotaline
2019 · Biomedicine & Pharmacotherapy · 35 citations
https://doi.org/10.1016/j.biopha.2019.108933
MicroRNA‑106a‑5p promotes the proliferation, autophagy and migration of lung adenocarcinoma cells by targeting LKB1/AMPK
2021 · Experimental and Therapeutic Medicine · 20 citations
https://doi.org/10.3892/etm.2021.10857
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat